Patents-Review.com
🔗 Permalink
Assignee profile:

RFS PHARMA, LLC

City:

Tucker, Georgia

Country:

United States

Published Applications:

11

Last publication date:

2014-08-21

Patent Grants:

8

Last grant date:

2017-11-07

Top Inventors for applications by RFS PHARMA, LLC

These are the the leading inventors for applications assigned to RFS PHARMA, LLC:

Recent patent applications by RFS PHARMA, LLC

RFS PHARMA, LLC based in Tucker, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-08-21 ✅ Patent 9,809,616 granted on 2017-11-07
US20140235566A1
Chemistry; metallurgy

Pyrimidine nucleosides and their monophosphate prodrugs for the treatment of viral infections and cancer

 #2 | 2014-07-31
US20140212382A1
Chemistry; metallurgy

PURINE MONOPHOSPHATE PRODRUGS FOR TREATMENT OF VIRAL INFECTIONS

 #3 | 2014-03-06 ✅ Patent 9,173,893 granted on 2015-11-03
US20140066395A1
Chemistry; metallurgy

Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections

 #4 | 2013-08-15 ✅ Patent 8,859,595 granted on 2014-10-14
US20130210774A1
Human necessities

Potent and selective inhibitors of hepatitis C virus

 #5 | 2012-06-07
US20120142627A1
Human necessities

MONOPHOSPHATE PRODRUGS OF DAPD AND ANALOGS THEREOF

 #6 | 2012-05-31 ✅ Patent 8,815,829 granted on 2014-08-26
US20120135951A1
Chemistry; metallurgy

3′-azido purine nucleotide prodrugs for treatment of viral infections

 #7 | 2012-05-24 ✅ Patent 8,729,014 granted on 2014-05-20
US20120129765A1
Chemistry; metallurgy

Specific HCV NS3 protease inhibitors

 #8 | 2012-02-16 ✅ Patent 8,609,627 granted on 2013-12-17
US20120040924A1
Human necessities

Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections

 #9 | 2010-11-04
US20100279969A1
Chemistry; metallurgy

AZIDO PURINE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS

 #10 | 2007-09-27 ✅ Patent 8,895,531 granted on 2014-11-25
US20070225249A1
Chemistry; metallurgy

2′-fluoronucleoside phosphonates as antiviral agents

 #11 | 2006-09-21 ✅ Patent 7,560,550 granted on 2009-07-14
US20060211855A1
Chemistry; metallurgy

Method for the production of OH protected[4-(2.6-diamino-9H-purine-9-yl)-1.3-dioxolane-2-yl]methanol derivatives

Also check out RFS Pharma, LLC's (Tucker, United States) applicant profile with 1 patent applications submitted.

AssigneeID:

35013 ⎘